Molecular Diagnostics
Ultra-Fast Real-Time PCR Platform Could Revolutionize POC Molecular Diagnostics
An ultra-fast POC real-time PCR platform for infectious disease diagnostics that is currently under development will be able to deliver results within five minutes at a cost equivalent to antigen tests currently available in the market. More...08 Nov 2022
Personalizing Whole Genome Sequencing Doubles Diagnosis of Rare Diseases
A new study has found that tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases. Receiving a genetic diagnosis is important as it allows patients with rare diseases to receive access to family planning, specialized IVF, and drugs trials. More...08 Nov 2022
New Blood Test to Help Physicians Prevent Major Cardiovascular Events in Women with Lupus
A genetic precision medicine test for lupus patients could save lives by predicting heart disease before it happens and providing decision support for prophylactic therapies. The breakthrough approach characterizes inherited genetic markers in blood samples that drive pathways that can be targeted by drugs. More...08 Nov 2022
Accurate Genetic Assay Identifies Human Neutrophil Antigen 2 Deficiency
Human Neutrophil Antigen 2 (HNA-2) is one of the most important neutrophil antigens implicated in a number of human disorders. HNA-2 deficiency or HNA-2 null is a common phenotype observed in 3%–5% of US citizens. More...08 Nov 2022
New Immunoassay Specifically Measures Heart Attack-linked Blood Troponin Levels
A recently developed immunoassay for measurement of intact troponin molecules in the blood is able to differentiate patients suffering from myocardial infarction (MI) from those with other transient or chronic conditions. More...03 Nov 2022
New
Gold Member
Troponin T QC
Troponin T Quality Control
New
DNA topoisomerase I ELISA
Anti-Scl-70 ELISA Test
New
EBV DNA Quantitative Fluorescence Diagnostic Kit
S3015E EBV
In Other News
A Procedure for Early Diagnosis of Pancreatic Cancer
Pathogen Analyzer Combines Advantages of Antigen and PCR Testing
Fast, Open and Digitalized PCR Platform Produces Results in 15 Minutes
Novel Phage- and CRISPR-Based Approaches to Enable Diagnosis of Sepsis in Blood Samples
New Test Identifies Women Less Likely to Respond to Standard Breast Cancer Treatment
New Test Detects Antibodies Responsible for Thromboses and Miscarriages
New Molecular Diagnostic System to Expand Access to PCR Testing in the U.S.
Novel Nanopore-Based Technology Rapidly and Precisely Detects Pathogens for Cancer Patients
Blood Test Accurately Diagnoses Early-Stage Osteoarthritis
Next-Gen Whole Blood DNA Collection and Extraction Kit to Introduce Cutting-Edge Capabilities
Liquid Biopsies Can Identify Cancer Patients at Higher Risk of Developing Additional Blood Cancers
World’s First Portable, High Yield Sequencer Provides Comprehensive DNA Analysis for Anyone, Anywhere
Diagnostic Tool Applies Machine Learning to Identify and Predict Sepsis Cases
Hematological Neoplasm Cytogenetics Profiled With Optical Genome Mapping
Super-Enhancer Induces Oncogenic Driver in Colorectal Carcinoma
Simple Blood Test Could Offer Smarter Treatment for Children’s Cancer
AI Diagnostic Tool Could Deliver Results in Two Minutes Using Fingertip Sample
Swab Test Identifies Dangerous Cervical Cell Changes Years Before They Occur
Periodontal Rapid Diagnostic Test Could Calculate Risk for Heart and Lung Disease
AI-Based Prenatal Blood Test Identifies Dangerous Fetal Heart Defects before Birth
Gene Expression Profiling of Mucinous Ovarian Tumors Identifies Prognosis Markers
Link Identified Between Mitochondria and Pancreatic Cancer Risk
Nucleic Acid Amplification Technology to Help Develop Instrument-Free Assays
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
